ClinicalTrials.gg
Not yet recruitingNCT07359274Updated Jan 22, 2026

Effects of Neurodynamic and Carpal Bone Mobilization in Mild-to-Moderate Carpal Tunnel Syndrome

An interventional study of Neurodynamic mobilization and Carpal bone mobilization in Carpal Tunnel Syndrome and Splints, sponsored by Kutahya Health Sciences University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-01-22.

Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Non-randomized
Ages
20 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 130 studies in Carpal Tunnel Syndrome with a site in Turkey — 36 open to participants now, 41 under way, none of them phase 3. Carpal Tunnel Syndrome · Turkey.

Planned enrollment
10th of 82
93 · median 60
Started
2026
with 19 others
No phase
75 of 130
21 open now
Primary completion
2027-01
later than 31 of 40 live
Registered
106th of 130
by date
Lead sponsor
7 of 130
Kutahya Health Sciences University

Among the 130 studies in Carpal Tunnel Syndrome with a site in Turkey, this one is the 10th largest by planned enrollment of the 82 interventional ones that give a count, is one of 20 that started in 2026, is one of 75 with no phase, reaches primary completion later than 31 of the 40 other live ones, and was the 106th registered.

Carpal Tunnel Syndrome

591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.

Browse Carpal Tunnel Syndrome studies →

Open to participants now

36 of the 130 studies in Carpal Tunnel Syndrome with a site in Turkey are open now. Recruiting first, the newest first:

31 more — sign in →

All 36 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 20 Years to 55 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 130 studies in Carpal Tunnel Syndrome with a site in Turkey, or all of them as a file.
02

Study summary

Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy caused by compression of the median nerve at the wrist. Conservative interventions such as splinting and manual therapy are frequently used in individuals with mild-to-moderate CTS. Neurodynamic mobilization and carpal bone mobilization aim to improve neural and soft tissue mobility; however, their comparative effects on clinical outcomes and median nerve morphology are not fully understood.

This interventional, non-randomized clinical study aims to compare the clinical and ultrasonographic effects of neurodynamic mobilization plus splinting, carpal bone mobilization plus splinting, and splinting alone in patients with mild-to-moderate CTS. Ninety-three participants diagnosed with mild-to-moderate carpal tunnel syndrome based on electrodiagnostic criteria will be included. Participants will be allocated into three parallel groups without randomization. All participants will receive a neutral-position wrist splint as standard conservative care.

Two intervention groups will additionally receive either neurodynamic mobilization exercises or carpal bone mobilization techniques administered by a physiotherapist for four weeks. Clinical outcomes and median nerve morphology will be evaluated at baseline and immediately after the intervention period.

The primary outcome is the change in the Boston Carpal Tunnel Questionnaire score. Secondary outcomes include pain intensity, neuropathic pain, functional disability, muscle strength, pressure pain threshold, and ultrasonographic measurements of the median nerve.

03

Conditions studied

  • Carpal Tunnel Syndrome
  • Splints
04

Who can participate

Ages eligible
20 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of mild-to-moderate carpal tunnel syndrome confirmed by electrodiagnostic testing
  • CTS symptoms for at least 3 months
  • Ability to provide

Exclusion criteria

Exclusion Criteria:

  • Previous carpal tunnel surgery
  • Diabetes mellitus or polyneuropathy
  • Cervical radiculopathy
  • Pregnancy or breastfeeding
  • Central nervous system disorders
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
93 participants (estimated)

Study arms

  • Experimental
    neurodynamic mobs in addition splint

    Median nerve neurodynamic mobilization exercises administered by a physiotherapist for 4 weeks in addition to night-time wrist splint use

    Other: Neurodynamic mobilization · Other: Splint

  • Experimental
    Carpal Bone Mobilization + Splint

    Carpal bone mobilization techniques administered by a physiotherapist for 4 weeks in addition to night-time wrist splint use.

    Other: Carpal bone mobilization · Other: Splint

  • Active comparator
    Splint only

    Neutral-position wrist splint worn at night for 4 weeks.

    Other: Splint

Interventions

  • OtherNeurodynamic mobilization

    Median nerve neurodynamic mobilization exercises performed 5 sessions per week for 4 weeks.

  • OtherCarpal bone mobilization

    Manual carpal bone mobilization techniques applied 5 sessions per week for 4 weeks.

  • OtherSplint

    Neutral-position wrist splint used during night-time for 4 weeks.

06

What researchers measure

Primary outcomes

  1. Boston Carpal Tunnel Questionnaire (BCTQ) Total Score

    Change in Boston Carpal Tunnel Questionnaire (BCTQ) Total Score

    Time frame: Baseline to 4 weeks

Secondary outcomes

  1. Visual Analog Scale (VAS)

    Pain intensity measured using a 10-cm visual analog scale.

    Time frame: Baseline to 4 weeks

  2. Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)

    Change in Neuropathic Pain Score Assessed by Leeds Assessment of Neuropathic Symptoms and Signs (LANSS).

    Time frame: Baseline to 4 weeks

  3. Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH)

    Change in Upper Extremity Disability Assessed by Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH).

    Time frame: Baseline to 4 weeks

  4. Grip Strength

    Change Grip strength measured using a Jamar dynamometer.

    Time frame: Baseline to 4 weeks

  5. Pinch Strength

    Change in Pinch Strength measured using a Pinchmeter.

    Time frame: Baseline to 4 weeks

  6. Pressure Pain Threshold

    Change in pressure pain threshold assessed using J -Tech algometer.

    Time frame: Baseline to 4 weeks

  7. Median Nerve Cross-Sectional Area

    Change in Median Nerve Cross-Sectional Area Assessed by Ultrasonography.

    Time frame: Baseline to 4 weeks

07

Study locations

1 site
  • Kutahya Health Sciences University Yoncalı Physical Therapy and Rehabilitation Hospital
    Kütahya, Yoncalı 43000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2026; primary completion for Jan 2027, 12 months later.

Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's planned 12 months is close to that.

Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2026
First posted
Jan 22, 2026
StartEst.
Jan 15, 2026
Primary completionEst.
Jan 15, 2027
CompletionEst.
Mar 15, 2027
Last update
Jan 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07359274
Responsible party
Merve Akdeniz Leblebicier (Assoc. Prof., Kutahya Health Sciences University) — Principal investigator
First posted
Jan 22, 2026
Start date
Jan 15, 2026 (estimated)
Primary completion
Jan 15, 2027 (estimated)
Completion
Mar 15, 2027 (estimated)
Last update
Jan 22, 2026

Study contacts

Merve Akdeniz Leblebicier, MD
Contact
merve1985akdeniz@hotmail.com
00902742600043 ext. 4343
Esengül Alıcı, MD
Contact
essengulalici@gmail.com
00902742600043 ext. 4343
Merve Akdeniz Leblebicier, MD
principal investigator · Kutahya Health Sciences University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion